-
how epigenetic changes drive tumorigenesis and drug resistance. The Zhang laboratory is one of the first laboratories that discovered how onco-histone mutations, H3K27M (found in diffuse intrinsic
-
discoveries, and service to society. For more than 250 years, Columbia has been a leader in higher education in the nation and around the world, offering a broad range of academic inquiry in various fields
-
variety of systems including yeast, mouse embryonic stem cells and human cells. Our second long-term goal is to determine how epigenetic changes drive tumorigenesis and drug resistance. The Zhang laboratory
-
commitment to attract and engage the best minds in pursuit of greater human understanding, pioneering new discoveries, and service to society. For more than 250 years, Columbia has been a leader in higher
-
resistance liabilities for antimalarial compounds in the preclinical stages of discovery or development. Specifically, this will include culturing malaria parasites, performing drug dose-response assays